[Treatment of general psychovegetative disorders with a single night dose of dipotassium-clorazepate within a multicenter study (author's transl)].
The therapeutical effect of Tranxilium was studied in an open multicenter study by 66 general practitioners and 26 specialists. 1.027 patients were treated with Tranxilium 20, given in a single dose at night, for a period of three weeks. During this time, the patient's psychic status and functional organic disorders were assessed by means of rating scales. A complete medical assessment followed at the end of the study. States of anxiety, restlessness, depressive mood, irritation and insomnia as well as functional organic disorders improved significantly (p is less than 0.001) already after the first week of treatment. At the end of treatment, with the majority of patients the above symptoms had either completely disappeared or were found only to a small extent. In 85% of the patients, all investigators rated the stabilization and brightening effect on psychic conditions as well as the harmonizing effect on disturbed organic functions as "very good" to "good". In 89% of the patients, the overall therapeutic success was judged as "very good" to "good". The overall tolerance was excellent in 96% of the cases.
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D000928:Antidepressive Agents; D001007:Anxiety; D002318:Cardiovascular Diseases / Q000188:drug therapy; D003009:Clorazepate Dipotassium / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006801:Humans; D011602:Psychophysiologic Disorders / Q000188:drug therapy*; D012877:Skin Manifestations; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D003009:Clorazepate Dipotassium
Die Behandlung psychovegetativer Allgemeinstörungen Mit Einer Abendlichen Einmaldosis von Dikaliumclorazepat Im Rahmen Einer Multicenter-Studie.